aTyr Pharma (NASDAQ:ATYR – Get Free Report) had its target price cut by investment analysts at Royal Bank Of Canada from $40.00 to $6.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has a “sector perform” rating on the stock. Royal Bank Of Canada‘s price target indicates a potential […]

Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) had its price objective lowered by research analysts at Piper Sandler from $43.00 to $28.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has a “neutral” rating on the specialty pharmaceutical company’s stock. Piper Sandler‘s price objective points to a […]

Atlassian (NASDAQ:TEAM – Get Free Report) had its price objective reduced by analysts at BTIG Research from $260.00 to $240.00 in a report issued on Friday, Benzinga reports. The firm presently has a “buy” rating on the technology company’s stock. BTIG Research‘s target price would indicate a potential upside of 30.94% from the stock’s previous […]

GlobalFoundries (NASDAQ:GFS – Get Free Report) had its target price dropped by investment analysts at UBS Group from $48.00 to $43.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group‘s price objective points to a potential upside of 18.38% from the […]

Aehr Test Systems (NASDAQ:AEHR – Get Free Report) had its target price decreased by investment analysts at Lake Street Capital from $110.00 to $90.00 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the semiconductor company’s stock. Lake Street Capital‘s price objective suggests a potential upside […]

Cerebras Systems (NASDAQ:CBRS – Get Free Report) had its price objective dropped by equities research analysts at UBS Group from $330.00 to $250.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group‘s target price indicates a potential upside of […]

Mobileye Global (NASDAQ:MBLY – Get Free Report) had its price objective decreased by research analysts at BNP Paribas Exane from $7.50 to $6.50 in a research report issued on Monday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. BNP Paribas Exane‘s price target points to a potential upside of 12.95% from […]

Affirm (NASDAQ:AFRM – Get Free Report) had its target price lowered by stock analysts at Morgan Stanley from $82.00 to $79.00 in a research note issued on Monday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Morgan Stanley‘s target price would indicate a potential upside of 13.17% from the company’s […]

Southern Missouri Bancorp (NASDAQ:SMBC – Get Free Report) had its price target reduced by investment analysts at Piper Sandler from $83.00 to $74.00 in a report released on Monday, Benzinga reports. The brokerage currently has a “neutral” rating on the savings and loans company’s stock. Piper Sandler‘s price target points to a potential upside of […]